Hsueh-Sheng Chiang

Dr. Hsueh-Sheng Chiang

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JHJohn HartJr
John HartJr
GTGail Tillman
Gail Tillman
MKMichael A Kraut
Michael A Kraut
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
JSJeremy F Strain
Jeremy F Strain
RWRichard J Whitley
Richard J Whitley
West Nile Virus (WNV) is a mosquito-borne flavivirus that has caused ongoing seasonal epidemics in the United States since 1999. It is estimated that ≤1% of WNV-infected patients will develop neuroinvasive disease (West Nile encephalitis and/or myelitis) that can result in debilitating morbidities and long-term sequelae. It is essential to collect longitudinal information about the recovery process and to characterize predicative factors that may assist in therapeutic decision-making in the future. We report a longitudinal study of the neurological outcomes (as measured by neurological examination, Glascow Coma Scale, and Modified Mini-Mental State Examination) for 55 subjects with WNV neuroinvasive disease (confirmed by positive CSF IgM) assessed on day 7, at discharge, and on days 14, 30, and 90. The neurological outcome measures were coma (presence and degree), global cognitive status, presence of cranial neuropathy, tremors and/or weakness. At initial clinical presentation 93% presented with a significant neurological deficit (49% with weakness, 35% with tremor, and 16% with cranial neuropathy). The number of patients with a cognitive deficit fell from 25 at initial evaluation to 9 at their last evaluation. Cranial neuropathy was present in 9 at onset and in only 4 patients at study conclusion. Of the 19 patients who had a tremor at enrollment, 11 continued to exhibit a tremor at follow-up. Seven patients died after initial enrollment in the study, with 5 of those having presented in a coma. The factors that predict either severity or long-term recovery of neurological function include age (older individuals were weaker at follow-up examination), gender (males recovered better from coma), and presentation in a coma with cranial nerve deficits (had a poorer recovery particularly with regard to cognition). This study represents one of the largest clinical investigations providing prospectively-acquired neurological outcomes data among American patients with WNV central nervous system disease. The findings show that the factors that influence prognosis from the initial presentation include age, gender, and specific neurological deficits at onset. ClinicalTrials.gov identifier: NCT00138463 and NCT00069316 .

1 May 2018 in Neuropsychology
Verified
Journal Article
Open access
JSJeff Schaffert
Jeff Schaffert
CLChristian LoBue
Christian LoBue
CWCharles L. White
Charles L. White
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
NDNyaz Didehbani
Nyaz Didehbani
CCC. Munro Cullum
C. Munro Cullum
To evaluate whether a history of traumatic brain injury (TBI) with reported loss of consciousness (LOC) is a risk factor for earlier onset of Alzheimer's disease (AD) in an autopsy-confirmed sample. Data from 2,133 participants with autopsy-confirmed AD (i.e., at least Braak neurofibrillary tangle stages III to VI and CERAD neuritic plaque score moderate to frequent) were obtained from the National Alzheimer's Coordinating Center (NACC). Participants were categorized by presence/absence of self-reported remote (i.e., >1 year prior to their first Alzheimer's Disease Center visit) history of TBI with LOC (TBI+ vs. TBI-). Analyses of Covariance (ANCOVA) controlling for sex, education, and race compared groups on clinician-estimated age of symptom onset and age of diagnosis. Average age of onset was 2.34 years earlier (p = .01) for the TBI+ group (n = 194) versus the TBI- group (n = 1900). Dementia was diagnosed on average 2.83 years earlier (p = .002) in the TBI+ group (n = 197) versus the TBI- group (n = 1936). Using more stringent neuropathological criteria (i.e., Braak stages V-VI and CERAD frequent), both age of AD onset and diagnosis were 3.6 years earlier in the TBI+ group (both p's < .001). History of TBI with reported LOC appears to be a risk factor for earlier AD onset. This is the first study to use autopsy-confirmed cases, supporting previous investigations that used clinical criteria for the diagnosis of AD. Further investigation as to possible underlying mechanisms of association is needed. (PsycINFO Database Record

1 July 2013 in Brain and Language
Verified
Journal Article
Closed access
JHJohn Hart
John Hart
AMAnd Mandy J. Maguire
And Mandy J. Maguire
MMMichael Motes
Michael Motes
RMRaksha Anand Mudar
Raksha Anand Mudar
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
MKMichael A. Kraut
Michael A. Kraut

22 January 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
RMRaksha A. Mudar
Raksha A. Mudar
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
JEJustin Eroh
Justin Eroh
LNLydia T Nguyen
Lydia T Nguyen
AMAnd Mandy J. Maguire
And Mandy J. Maguire
JHJohn Hart
John Hart
We examined the effects of amnestic mild cognitive impairment (aMCI) on behavioral (response times and error rates) and scalp-recorded event-related potential (ERP) measures of response execution and inhibition, using Go/NoGo tasks involving basic and superordinate semantic categorization. Twenty-five aMCI (16 F; 68.5±8 years) and 25 age- and gender-matched normal control subjects (16 F; 65.4±7.1 years) completed two visual Go/NoGo tasks. In the single car task, responses were made based on single exemplars of a car (Go) and a dog (NoGo) (basic). In the object animal task, responses were based on multiple exemplars of objects (Go) and animals (NoGo) (superordinate). The aMCI subjects had higher commission errors on the NoGo trials compared to the control subjects, whereas both groups had comparable omission errors and reaction times during the Go trials. The aMCI subjects had significantly prolonged N2 ERP latency during Go and NoGo trials across tasks compared to the controls. Both groups showed similar categorization effects and response type effects in N2/P3 ERP latencies and P3 amplitude. Our findings indicate that altered early neural processing indexed by N2 latency distinguishes subjects with aMCI from controls during the Go/NoGo task. Prolonged Go-N2 latency in aMCI appears to precede behavioral changes in response execution, whereas prolonged NoGo-N2 latency underlies behavioral deterioration in response inhibition.

1 July 2015 in Behavioural Brain Research
Verified
Journal Article
Closed access
RMRaksha A. Mudar
Raksha A. Mudar
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
AMAnd Mandy J. Maguire
And Mandy J. Maguire
JSJeffrey S. Spence
Jeffrey S. Spence
JEJustin Eroh
Justin Eroh
JHJohn Hart
John Hart

23 May 2017 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
LNLydia T Nguyen
Lydia T Nguyen
RMRaksha A. Mudar
Raksha A. Mudar
HCHsueh-Sheng CHIANG
Hsueh-Sheng CHIANG
Julie M. SchneiderJulie M. Schneider
Julie M. Schneider
AMAnd Mandy J. Maguire
And Mandy J. Maguire
JHJohn Hart
John Hart
Growing evidence suggests that cognitive control processes are impaired in amnestic mild cognitive impairment (aMCI); however the nature of these alterations needs further examination. The current study examined differences in electroencephalographic theta and alpha power related to cognitive control processes involving response execution and response inhibition in 22 individuals with aMCI and 22 age-, sex-, and education-matched cognitively normal controls. Two Go/NoGo tasks involving semantic categorization were used. In the basic categorization task, Go/NoGo responses were made based on exemplars of a single car (Go) and a single dog (NoGo). In the superordinate categorization task, responses were made based on multiple exemplars of objects (Go) and animals (NoGo). Behavioral data showed that the aMCI group had more false alarms during the NoGo trials compared to controls. The EEG data revealed between group differences related to response type in theta (4-7 Hz) and low-frequency alpha (8-10 Hz) power. In particular, the aMCI group differed from controls in theta power during the NoGo trials at frontal and parietal electrodes, and in low-frequency alpha power during Go trials at parietal electrodes. These results suggest that alterations in theta power converge with behavioral deterioration in response inhibition, whereas alterations in low-frequency alpha power appear to precede behavioral changes in response execution. Both behavioral and electrophysiological correlates combined provide a more comprehensive characterization of cognitive control deficits in aMCI.